Searchable abstracts of presentations at key conferences in endocrinology

ea0016p458 | Neuroendocrinology | ECE2008

Effect of GH replacement on coronary flow reserve (CFR) and on some cardiovascular risk factors in adult GHD patients

Boschetti Mara , Agosti Sergio , Albanese Valeria , Casalino Laura , Vera Lara , Goglia Umberto , Paolo Bezante Gian , Ferone Diego , Minuto Francesco

GH deficiency (GHD) negatively influences cardiovascular function directly by impairing cardiac filling, performance, and contractility and indirectly by inducing atherosclerotic changes, hypercoagulability, abdominal obesity, insulin resistance, dislipidemia, endothelial dysfunction, etc. This accounts for the reduced life expectancy and increased risk of death for vascular disease in these patients.CFR represents the capacity of the coronary circulatio...

ea0014p114 | (1) | ECE2007

Somatostatin and dopamine receptor regulation and effects of a new somatostatin/dopamine chimeric compound on cell proliferation of the human androgen-dependent prostate cancer cell line LNCaP

Arvigo Marica , Ruscica Massimiliano , Dozio Elena , Culler Michael D , Minuto Francesco , Motta Marcella , Magni Paolo , Ferone Diego

The increasing use of somatostatin (SRIF) analogues prompted extensive investigations on SRIF receptor (SSR) in human tumours. Human prostate cancer (PCa) may differentially express SSRs from the normal tissue. Moreover, SSR and dopamine (D) receptors (DR) may interact to form homo- and heterodimers with enhanced functional activity. In the present study, using the human androgen-dependent PCa cell line LNCaP, we investigated: 1) SSR and DR subtype expression in different cult...

ea0014p115 | (1) | ECE2007

Somatostatin receptor regulation and effects of somatostatin and somatostatin analogues on cell proliferation of the human androgen-dependent prostate cancer cell line LNCaP

Ruscica Massimiliano , Arvigo Marica , Dozio Elena , Culler Michael D , Minuto Francesco , Motta Marcella , Ferone Diego , Magni Paolo

Somatostatin (SRIF) has been demonstrated to inhibit in vitro proliferation of normal and transformed cells via SRIF receptors (SSRs). Moreover, like other neuroendocrine molecules, SRIF and SSRs may play a significant role in the progression and neuroendocrine differentiation of human prostate cancer (PCa). However, conflicting results have been reported in the literature on SSR heterogeneity and specific cell localization in PCa. In the present study, using the human ...

ea0014p185 | (1) | ECE2007

Auxological and IGF system parameters in African in comparison with western countries normal children

Boschetti Mara , Piredda Sabrina , Sidoti Marilena , Di Battista Eliana , Larizza Daniela , Ferone Diego , Barreca Antonina , Minuto Francesco

Growth is an integrated process, resulting from the response of cells to nutrient availability and to hormonal status. Nutrients, in turn, are important regulators of IGF-IGFBP system which are critical regulators of growth. Genetic factors seem to be very important determinant of final stature in countries with high quality of life at variance with underprivileged countries where food intake deficiency is critical. The aim of our study was to evaluate the influence of environ...

ea0056p34 | Adrenal cortex (to include Cushing's) | ECE2018

Value of 131I-Norcholesterol scintigraphy in the evaluation of primary hyperaldosteronism

Casteras Anna , Villasboas-Rosciolesi Diego , Garcia-Burillo Amparo , Espinel Eugenia , Zafon Carles , Mesa Jordi , Castell-Conesa Joan

Background: 131I-norcholesterol scintigraphy (INCS) is currently not considered a main confirmatory and localizing study in primary aldosteronism (PA), however few recent data is available. On the other hand, adrenal venous sampling (AVS) is technically difficult, and may also lead to erroneuos diagnosis.Aim: To describe the performance of INCS, done under dexamethasone (DXM) supression, in daily practice.Patients and methods: Retr...

ea0056p292 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Effects of atorvastatin and ezetimibe therapy on LDL Cholesterol. A systematic review and meta-analysis of randomized controlled trial

Buendia Richard , Zambrano Monica , Buendia Andres , Vargas Tatiana , Morales Alejandra , Alejo Adriana , Cardenas Santiago , Mier Heidy , Sanchez Diego , Arrautt Johann

Background: Evidence has shown that the use of high doses of statins is associated with lower levels of LDL cholesterol and a decrease in cardiovascular events. Likewise, the use of high doses of statins may increase the risk of myopathy, elevation of liver enzymes, renal failure and cognitive alterations. We conducted a systematic review with a meta-analysis of all RCTs investigating the impact of atorvastatin and ezetimibe therapy on levels of LDL cholesterol vs high doses o...

ea0092ps2-15-09 | Hyperthyroidism | ETA2023

Long-term follow-up after antithyroid drug treatment withdrawal in patients with the first episode of graves` disease: a retrospective cohort study in spain

Meneses Diego , Sanchez Lechuga Begona , Velez Romero Maria , Sierra Poyatos Roberto , Vazquez Martinez Clotilde , Cardenas Salas Jersy

Background: Despite a high relapse rate, antithyroid drugs (ATDs) remain the first-line therapy of GravesÂ’ disease (GD). Long-term follow-up studies of GD in Spain are scarce. Our aims were to identify clinical differences between patients who relapsed vs those who attained remission and to describe the relapse rate of GD after ATD withdrawal.Methods: We analyzed patients with the first episode of GD who were treated with ATDs during 2010 - 2020, in...

ea0098o6 | Other | NANETS2023

PRESTO 3: An international, simulated-use study assessing preferences of nurses between two lanreotide syringes (Somatuline® Autogel® vs Pharmathen)

Ferone Diego , Martin Wendy , Williams Jessica , Houchard Aude , Pommie Christelle , Mai Truong-Thanh Xuan , Ribeiro-Oliveira Jr. Antonio , Grossman Ashley

Background: Patients with neuroendocrine tumours (NETs) and acromegaly are commonly treated with somatostatin analogs (SSAs), such as octreotide and lanreotide depot formulations. The Pharmathen syringe is now available in several European countries and the USA for lanreotide depot injection. When using SSAs, confidence in and ease of use with syringes are important for decision-making in long-term therapy. The aim of the PRESTO 3 study was to compare nursesÂ’ preference f...

ea0099ep1112 | Pituitary and Neuroendocrinology | ECE2024

Acromegaly in humans, cats and dogs: epidemiological, pathophysiological, clinical and management resemblances and differences

Lopes-Pinto Mariana , Lunet Marques Patricia , Paula Ricca Lacerda Nobre M Caetano Ema , Miceli Diego , Oliveira Leal Rodolfo , Marques Pedro

Background: Acromegaly is a rare disorder associated with excessive levels of growth hormone(GH) and insulin-like growth factor-1(IGF-1). GH/IGF-1 excess leads to morphologic craniofacial and acral changes as well as cardiometabolic complications, but the phenotypic changes and presentation differ across species.Aim: To present the resemblances and distinctive features of acromegaly in humans, cats and dogs.Methods: A literature re...

ea0099ep218 | Thyroid | ECE2024

Analysis of clinical and ultrasound results after treatment with percutaneous ethanol injection in benign cystic thyroid nodules

Jose Simon Frapolli Victor , Fernandez Garcia Diego , Maria Gomez Perez Ana , Mancha Doblas Isabel , Tinahones Madueno Francisco

Introduction: Percutaneous ethanol injection (PEI) or thyroid enolisation is a minimally invasive technique applicable to benign cystic thyroid nodules, not adhered to neighbouring structures, due to local compressive symptoms or aesthetic discomfort. Classically, the treatment of choice for these nodules has been simple aspiration, followed by surgery in refractory cases. Currently, PEI has emerged as an alternative to surgery due to its high efficacy, speed, safety, low rate...